Cryoport Reports Q1 2025 Earnings with Revenue Growth and Strategic Partnership
Cryoport (CYRX) reported Q1 2025 earnings with $41 million in revenue from continuing operations, a 10% year-over-year increase. The company also announced a strategic partnership with DHL, selling CryoPDP for $195 million enterprise value, expected to close in Q2 or Q3 2025. Life Sciences Services revenue grew 17% year-over-year, and the company confirmed 2025 revenue guidance of $165 million to $172 million.
Tickers: $CYRX
Topics: acquisition clinical trials life sciences revenue growth strategic partnership